<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Cash-strapped Repros Therapeutics warns of potential bankruptcy]]></title><link>http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/</guid><comments>http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/earnings-reports/" rel="tag">Earnings Reports</a>, <a href="http://www.bloggingstocks.com/category/bad-news/" rel="tag">Bad News</a>, <a href="http://www.bloggingstocks.com/category/employees/" rel="tag">Employees</a></p><p><img  border="1" hspace="4" alt="" vspace="4" align="right" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2009/08/logo-rprx.gif" /><a href="http://finance.aol.com/quotes/repros-therapeutics-inc/rprx/nas">Repros Therapeutics</a> (NASDAQ: <a href="http://finance.aol.com/quotes/repros-therapeutics-inc/rprx/nas">RPRX</a>) easily takes the prize for most dismal earnings report of the day. Not only did the drug firm report a <a href="http://money.aol.com/rtn/pr/repros-therapeutics-inc-reports-second-quarter-2009-financial-results-and-provides-update/rfid242295540?channel=pf">wider-than-forecast second-quarter loss</a>, it also warned that bankruptcy is a real possibility unless the company can secure significant additional capital.</p>
<p>Specifically, Repros confessed to a second-quarter net loss of $8.9 million, or 59 cents per share, compared to Wall Street's consensus estimate for a loss of 46 cents per share. The company chalked up its poor results to a 16% annualized increase in clinical development activities for Proellex -- which has been placed on clinical hold by the FDA -- as well as a 60% year-over-year jump in general and administration expenses.</p><p><a href="http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/" rel="bookmark">Continue reading <em>Cash-strapped Repros Therapeutics warns of potential bankruptcy</em></a></p><p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/">Cash-strapped Repros Therapeutics warns of potential bankruptcy</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Mon, 17 Aug 2009 11:40:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/19131302/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2009/08/17/cash-strapped-repros-therapeutics-warns-of-potential-bankruptcy/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>bankruptcy</category><category>capital</category><category>Chapter 11</category><category>FDA</category><category>going concern</category><category>inthenews</category><category>pay cuts</category><category>PayCuts</category><category>Proellex</category><category>Repros Therapeutics</category><category>RPRX</category><category>second-quarter earnings</category><category>short sellers</category><dc:creator><![CDATA[Elizabeth Harrow]]></dc:creator><pubDate>Mon, 17 Aug 2009 11:40:00 EST</pubDate></item></channel></rss>
